Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Amarin Corporation stock

Own Amarin Corporation stock in just a few minutes.

Posted

Fact checked

Amarin Corporation plc is a biotechnology business based in the US. Amarin Corporation shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Amarin Corporation employs 965 staff and has a trailing 12-month revenue of around USD$546 million.

How to buy shares in Amarin Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Amarin Corporation Find the stock by name or ticker symbol: AMRN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Amarin Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Amarin Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Amarin Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Amarin Corporation share price

Use our graph to track the performance of AMRN stocks over time.

Amarin Corporation shares at a glance

Information last updated 2020-09-25.
52-week rangeUSD$3.36 - USD$24.67
50-day moving average USD$5.7091
200-day moving average USD$7.1299
Wall St. target priceUSD$11.1
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.266

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Available asset types Stock trade fee Option trade fee Annual fee
Vanguard
Stocks,Mutual funds,ETFs,Forex
$0
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
Stocks,Options,ETFs,Cryptocurrency
$0
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
TD Ameritrade
Stocks,Bonds,Options,Mutual funds,ETFs,Forex,Futures
$0
or $25 If it is broker-assisted
$0 + $0.65/contract,
or $25 Broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Interactive Brokers
Stocks,Bonds,Options,Mutual funds,Index funds,ETFs,Forex,Futures,Cash
$0
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Tastyworks
Stocks,Options,ETFs,Futures
$0
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amarin Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amarin Corporation price performance over time

Historical closes compared with the last close of $N/A

1 week (2020-09-17) -100.00%
1 month (2020-08-27) -100.00%
3 months (2020-06-26) -100.00%
6 months (2020-03-27) -100.00%
1 year (2019-09-27) -100.00%
2 years (2018-09-27) -100.00%
3 years (2017-09-27) -100.00%
5 years (2015-09-25) -100.00%

Amarin Corporation financials

Revenue TTM USD$546 million
Gross profit TTM USD$333.7 million
Return on assets TTM -1.81%
Return on equity TTM -3.33%
Profit margin -2.3%
Book value $1.544
Market capitalisation USD$1.4 billion

TTM: trailing 12 months

Shorting Amarin Corporation shares

There are currently 26.4 million Amarin Corporation shares held short by investors – that's known as Amarin Corporation's "short interest". This figure is 5% down from 27.8 million last month.

There are a few different ways that this level of interest in shorting Amarin Corporation shares can be evaluated.

Amarin Corporation's "short interest ratio" (SIR)

Amarin Corporation's "short interest ratio" (SIR) is the quantity of Amarin Corporation shares currently shorted divided by the average quantity of Amarin Corporation shares traded daily (recently around 6.3 million). Amarin Corporation's SIR currently stands at 4.17. In other words for every 100,000 Amarin Corporation shares traded daily on the market, roughly 4170 shares are currently held short.

However Amarin Corporation's short interest can also be evaluated against the total number of Amarin Corporation shares, or, against the total number of tradable Amarin Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amarin Corporation's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Amarin Corporation shares in existence, roughly 70 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Amarin Corporation shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Amarin Corporation.

Find out more about how you can short Amarin Corporation stock.

Amarin Corporation share dividends

We're not expecting Amarin Corporation to pay a dividend over the next 12 months.

Have Amarin Corporation's shares ever split?

Amarin Corporation's shares were split on a 1:10 basis on 18 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin Corporation shares which in turn could have impacted Amarin Corporation's share price.

Amarin Corporation share price volatility

Over the last 12 months, Amarin Corporation's shares have ranged in value from as little as $3.36 up to $24.67. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin Corporation's is 2.66. This would suggest that Amarin Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Amarin Corporation overview

Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Frequently asked questions

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site